LOTUS PHARM CO LTD FDA Approval ANDA 215834

ANDA 215834

LOTUS PHARM CO LTD

FDA Drug Application

Application #215834

Documents

Letter2022-09-07

Application Sponsors

ANDA 215834LOTUS PHARM CO LTD

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2022-08-24STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

LOTUS PHARM CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215834
            [companyName] => LOTUS PHARM CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIDOSTAURIN","activeIngredients":"MIDOSTAURIN","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/24\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-08-24
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.